Skip to search formSkip to main contentSkip to account menu

1.2 ML alemtuzumab 10 MG/ML Injection [Lemtrada]

Known as: ALEMTUZUMAB 12 mg in 1.2 mL INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE [LEMTRADA], Lemtrada 12 MG in 1.2 ML Injection, Lemtrada 12 MG per 1.2 ML Injection 
National Institutes of Health

Related topics

Related topics

11 relations
Edetic Acid, Disodium SaltInjectionLemtradaMonobasic potassium phosphate

Broader (1)

alemtuzumab Injection [Lemtrada]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Alemtuzumab treatment in multiple sclerosis: real clinical experience
Alemtuzumab (Lemtrada®) je humanizovaná monoklonální protilátka určená k léčbě vysoce aktivní relaps-remitentní formy roztroušen… 
2016
2016
Zkušenosti s terapií alemtuzumabem v klinické praxi
Alemtuzumab (Lemtrada®) je humanizovana monoklonalni protilatka namiřena proti molekule CD 52, ktera se nachazi na povrchu… 
2011
2011
Genzyme-Sanofi buyout is second largest biotech deal ever
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)